202 related articles for article (PubMed ID: 16143737)
21. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
Brown E; Dunner DL; McElroy SL; Keck PE; Adams DH; Degenhardt E; Tohen M; Houston JP
Int J Neuropsychopharmacol; 2009 Jul; 12(6):773-82. PubMed ID: 19079815
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
Thase ME; Corya SA; Osuntokun O; Case M; Henley DB; Sanger TM; Watson SB; Dubé S
J Clin Psychiatry; 2007 Feb; 68(2):224-36. PubMed ID: 17335320
[TBL] [Abstract][Full Text] [Related]
23. Olanzapine/fluoxetine: a review of its use in the treatment of acute bipolar depression.
Deeks ED; Keating GM
Drugs; 2008; 68(8):1115-37. PubMed ID: 18484802
[TBL] [Abstract][Full Text] [Related]
24. A review of FDA-approved treatment options in bipolar depression.
McIntyre RS; Cha DS; Kim RD; Mansur RB
CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
[TBL] [Abstract][Full Text] [Related]
25. Olanzapine/fluoxetine combination for bipolar depression.
Shelton RC
Expert Rev Neurother; 2006 Jan; 6(1):33-9. PubMed ID: 16466309
[TBL] [Abstract][Full Text] [Related]
26. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
Shi L; Namjoshi MA; Swindle R; Yu X; Risser R; Baker RW; Tohen M
Clin Ther; 2004 Jan; 26(1):125-34. PubMed ID: 14996525
[TBL] [Abstract][Full Text] [Related]
27. [The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
D'iakonov AL; Lobanova IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11 Pt 2):61-6. PubMed ID: 23257758
[TBL] [Abstract][Full Text] [Related]
28. Olanzapine/fluoxetine: a review of its use in patients with treatment-resistant major depressive disorder.
Croxtall JD; Scott LJ
CNS Drugs; 2010 Mar; 24(3):245-62. PubMed ID: 20155998
[TBL] [Abstract][Full Text] [Related]
29. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
Citrome L
Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
[TBL] [Abstract][Full Text] [Related]
30. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
31. Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder.
Andersen SW; Clemow DB; Corya SA
J Clin Psychiatry; 2005 Nov; 66(11):1468-76. PubMed ID: 16420086
[TBL] [Abstract][Full Text] [Related]
32. Spotlight on olanzapine/fluoxetine in acute bipolar depression.
Deeks ED; Keating GM
CNS Drugs; 2008; 22(9):793-5. PubMed ID: 18698877
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: an integrated analysis.
Katagiri H; Tohen M; McDonnell DP; Fujikoshi S; Case M; Kanba S; Takahashi M; Gomez JC
Psychiatry Clin Neurosci; 2014 Jul; 68(7):498-505. PubMed ID: 24417745
[TBL] [Abstract][Full Text] [Related]
34. Olanzapine augmentation of fluoxetine in the treatment of pathological skin picking.
Christensen RC
Can J Psychiatry; 2004 Nov; 49(11):788-9. PubMed ID: 15633864
[No Abstract] [Full Text] [Related]
35. Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot study.
Corey-Lisle PK; Birnbaum H; Greenberg P; Marynchenko M; Dube S
Psychopharmacol Bull; 2003; 37(3):90-8. PubMed ID: 14608242
[TBL] [Abstract][Full Text] [Related]
36. Influence of fluoxetine on olanzapine pharmacokinetics.
Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D
AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
[TBL] [Abstract][Full Text] [Related]
37. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study.
Pollack MH; Simon NM; Zalta AK; Worthington JJ; Hoge EA; Mick E; Kinrys G; Oppenheimer J
Biol Psychiatry; 2006 Feb; 59(3):211-5. PubMed ID: 16139813
[TBL] [Abstract][Full Text] [Related]
38. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese JR; Elhaj O; Gajwani P; Gao K
J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
[TBL] [Abstract][Full Text] [Related]
39. Atypical antipsychotics in bipolar depression: potential mechanisms of action.
Yatham LN; Goldstein JM; Vieta E; Bowden CL; Grunze H; Post RM; Suppes T; Calabrese JR
J Clin Psychiatry; 2005; 66 Suppl 5():40-8. PubMed ID: 16038601
[TBL] [Abstract][Full Text] [Related]
40. Long-term observational comparison of risperidone and olanzapine in bipolar disorder.
Ghaemi SN; Hsu DJ; Rosenquist KJ; Katzow JJ; Goodwin FK
Ann Clin Psychiatry; 2004; 16(2):69-73. PubMed ID: 15328900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
